These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2982449)

  • 1. The Epstein-Barr virus as a model of virus-host interactions.
    Rickinson AB; Yao QY; Wallace LE
    Br Med Bull; 1985 Jan; 41(1):75-9. PubMed ID: 2982449
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune surveillance against Epstein-Barr virus.
    Moss DJ; Burrows SR; Khanna R; Misko IS; Sculley TB
    Semin Immunol; 1992 Apr; 4(2):97-104. PubMed ID: 1377517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation of latent infections caused by the Epstein-Barr virus in systemic lupus erythematosus].
    Anan'eva LP; Alekberova ZS; Nasonova VA; Stepina VN
    Revmatologiia (Mosk); 1986; (1):39-43. PubMed ID: 3012745
    [No Abstract]   [Full Text] [Related]  

  • 4. [The expression of periphery blood leucocyte CCR3 and CCR5 in the children with Epstein-Barr virus associated infectious mononucleosis].
    Qi TX; Gao GH; Liu SH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):355-7. PubMed ID: 21280323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis.
    Robinson JE
    Yale J Biol Med; 1982; 55(3-4):311-6. PubMed ID: 6295008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Epstein-Barr virus production in P3HR-1 cells by Epstein-Barr virus-seropositive human serum.
    Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Humphreys RE
    Intervirology; 1991; 32(1):37-51. PubMed ID: 1849877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
    Szigeti R; Klein E; Masucci MG; Ernberg I; Masucci G; Svedmyr E; Klein G
    Orv Hetil; 1982 May; 123(20):1217-21. PubMed ID: 6287380
    [No Abstract]   [Full Text] [Related]  

  • 8. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus.
    Rickinson AB
    Prog Brain Res; 1983; 59():189-202. PubMed ID: 6320264
    [No Abstract]   [Full Text] [Related]  

  • 9. The immune system as mediator of virus-associated bone marrow failure: B19 parvovirus and Epstein-Barr virus.
    Young NS; Baranski B; Kurtzman G
    Ann N Y Acad Sci; 1989; 554():75-80. PubMed ID: 2544123
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic tests: Epstein-Barr virus].
    Mizuno F
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():300-3. PubMed ID: 16111256
    [No Abstract]   [Full Text] [Related]  

  • 11. The Epstein-Barr virus and human lymphoproliferative disorders.
    Schnipper LE
    Prog Hematol; 1981; 12():275-97. PubMed ID: 6280236
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic significance of determining antibodies to antigens of the Epstein-Barr virus in infectious mononucleosis].
    Urazova LN; Podoplekin VD; Odintsova LN; Lepekhin AV
    Lab Delo; 1989; (5):73-4. PubMed ID: 2473271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epstein-Barr virus. Its participation in lymphoproliferative and anaplastic processes].
    Fejes M; Bachmann AE; Mochanko K
    Medicina (B Aires); 1978; 38(6 Pt 1):700-16. PubMed ID: 220495
    [No Abstract]   [Full Text] [Related]  

  • 14. [Present status of infectious mononucleosis and Epstein Barr virus].
    Ducroix JP; Smail A; Vovan AT; Devauchelle B; Baillet J
    LARC Med; 1984 Mar; 4(3):161-3. PubMed ID: 6325836
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein-Barr virus effect on frequency of functionally distinct T cell subsets in children with infectious mononucleosis.
    Sulik A; Oldak E; Kroten A; Lipska A; Radziwon P
    Adv Med Sci; 2014 Sep; 59(2):227-31. PubMed ID: 25051418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology and laboratory diagnosis of infectious mononucleosis: I. Epstein-Barr virus (EBV) mononucleosis.
    Escobar MR; Allison MJ; Dalton HP
    Va Med Mon (1918); 1970 Feb; 97(2):138-9. PubMed ID: 4367826
    [No Abstract]   [Full Text] [Related]  

  • 17. The sero-epidemiology of Epstein-Barr virus.
    Henle W; Henle G
    Adv Pathobiol; 1976; (5):5-17. PubMed ID: 220858
    [No Abstract]   [Full Text] [Related]  

  • 18. Infectious mononucleosis and Epstein-Barr virus in Japan. II. Cellular aspects.
    Takiuchi Y; Tatsumi E; Nasu K; Shirakawa S; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):864-71. PubMed ID: 6277135
    [No Abstract]   [Full Text] [Related]  

  • 19. The Epstein-Barr virus and its relationship to infectious mononucleosis in Air Force recruits.
    Ellenbogen C; Reinarz JA
    Mil Med; 1974 May; 139(5):371-3. PubMed ID: 4365024
    [No Abstract]   [Full Text] [Related]  

  • 20. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.